Weight, hormones, and metabolism are intimately connected and as more men and women begin GLP-1 therapy, its clear these medications can influence far more than body composition
Liberacet is a GLP-1 receptor agonist that mimics the effects of human GLP-1 , selectively binds to the GLP-1 receptor, increases cAMP release, promotes insulin secretion, inhibits glucagon secretion, and thus lowers blood sugar levels
Around 59% of participants were living with high blood pressure, and the average treatment period was 66 weeks
If not already doing so, individuals should be prepared to make lifestyle changes, including adopting a reduced-calorie eating pattern and increasing physical activity
The 90-day clinical check-in structure adds accountability that most telehealth clinics skip